These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1531817)

  • 1. Optimal dose regimen for paroxetine.
    Dunner DL; Dunbar GC
    J Clin Psychiatry; 1992 Feb; 53 Suppl():21-6. PubMed ID: 1531817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of paroxetine.
    Boyer WF; Feighner JP
    J Clin Psychiatry; 1992 Feb; 53 Suppl():3-6. PubMed ID: 1531819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety profile of paroxetine.
    Boyer WF; Blumhardt CL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():61-6. PubMed ID: 1531828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.
    Dunner DL; Cohn JB; Walshe T; Cohn CK; Feighner JP; Fieve RR; Halikas JP; Hartford JT; Hearst ED; Settle EC
    J Clin Psychiatry; 1992 Feb; 53 Suppl():57-60. PubMed ID: 1531827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB; Crowder JE; Wilcox CS; Ryan PJ
    Psychopharmacol Bull; 1990; 26(2):185-9. PubMed ID: 2146697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxetine: an overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression.
    Nemeroff CB
    J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):10S-17S. PubMed ID: 8106649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sertraline (Lustral) and paroxetine (Seroxat)--new drugs for the treatment of depression.
    Drug Ther Bull; 1991 Jun; 29(12):46-7. PubMed ID: 1834449
    [No Abstract]   [Full Text] [Related]  

  • 8. Paroxetine: pharmacokinetic and antidepressant effect in the elderly.
    Lundmark J; Scheel Thomsen I; Fjord-Larsen T; Manniche PM; Mengel H; Møller-Nielsen EM; Pauser H; Wålinder J
    Acta Psychiatr Scand Suppl; 1989; 350():76-80. PubMed ID: 2530794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxetine in major depression: a double-blind trial with imipramine and placebo.
    Cohn JB; Wilcox CS
    J Clin Psychiatry; 1992 Feb; 53 Suppl():52-6. PubMed ID: 1531826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients.
    Claghorn JL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():33-5. PubMed ID: 1531821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of paroxetine compared with placebo in outpatients with major depression.
    Rickels K; Amsterdam J; Clary C; Fox I; Schweizer E; Weise C
    J Clin Psychiatry; 1992 Feb; 53 Suppl():30-2. PubMed ID: 1531820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo-controlled trial of paroxetine in the treatment of major depression.
    Smith WT; Glaudin V
    J Clin Psychiatry; 1992 Feb; 53 Suppl():36-9. PubMed ID: 1531822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP; Boyer WF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for the long-term treatment of depression.
    Hirschfeld RM
    J Clin Psychiatry; 1994 Dec; 55 Suppl():61-9; discussion 70-1. PubMed ID: 7814359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
    Mendels J; Reimherr F; Marcus RN; Roberts DL; Francis RJ; Anton SF
    J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo.
    Peselow ED; Filippi AM; Goodnick P; Barouche F; Fieve RR
    Psychopharmacol Bull; 1989; 25(2):267-71. PubMed ID: 2532373
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind, placebo-controlled study of paroxetine in depressed outpatients.
    Kiev A
    J Clin Psychiatry; 1992 Feb; 53 Suppl():27-9. PubMed ID: 1531818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind comparison of paroxetine, imipramine, and placebo in major depression.
    Shrivastava RK; Shrivastava SH; Overweg N; Blumhardt CL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():48-51. PubMed ID: 1531825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The short- and long-term efficacy of paroxetine HCl: B. Data from a double-blind crossover study and from a year-long term trial vs. imipramine and placebo.
    Peselow ED; Filippi AM; Goodnick P; Barouche F; Fieve RR
    Psychopharmacol Bull; 1989; 25(2):272-6. PubMed ID: 2532374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.